Agenda Clinical Hematology & Oncology 2024

11 a.m.               

Registration Opens

11:30 a.m.         

Pre-Conference Symposium

Non-CME Activity Hosted by Agios Pharmaceuticals

Diagnostic Approach and Considerations in Patients With Hemolytic Anemia

Srikanth Nagalla, MD

View Invitation (PDF, 78 KB)

12:30 p.m.         

Break & View Exhibits

12:50 p.m.         

Welcome & Educational Overview

Michael P. Kosty, MD

Non-Malignant Hematology

Moderator: Emily Nagler, MD

1 p.m.                 

Thrombosis: 2024 Update

Stephan Moll, MD

1:30 p.m.                           

Management of Hematologic Conditions in Athletes

Raj Kasthuri, MD, MBBS

2 p.m.                 

Management of Autoimmune, Viral and Surgical-associated Anti-PF4 Disorders

Ted Warkentin, MD

2:30 p.m.                           

Panel Discussion/Q&A

3 p.m.                 

Break & View Exhibits

3:15 p.m.                           

Hemolytic Anemias – Autoimmune, Membrane and Enzyme Defects

Ilene Weitz, MD

3:45 p.m.                           

Heavy Menstrual Bleeding: Workup for Bleeding Disorder and Management

Alice Ma, MD

4:15 p.m.                           

Management of Simultaneous Venous and Arterial Thromboembolic Disease

Jori May, MD

4:45 p.m.                           

Panel Discussion/Q&A

Concurrent Breakout Sessions: Clinical Cases

5:15 p.m.                           

Breakout #1: Interesting Cases in Thrombosis

Stephan Moll, MD

Breakout #2: Interesting Cases in Platelet Disorders

Ted Warkentin, MD

Breakout #3: Interesting Cases in Bleeding

Alice Ma, MD

Breakout #4: Interesting Cases in Plasma Cell Dyscrasias

Morie Gertz, MD

6:15 p.m.                           

Adjourn

6:30 p.m.                           

Welcome & Networking Reception 

6:45 a.m.                           

Breakfast Symposium

Non-CME Activity Hosted by Rigel Pharmaceuticals

REZLIDIHIA Induces Durable Complete Remissions in Adult Patients with Relapsed/Refractory mIDH1 AML

Mojtaba Akhatri, MD

6:45 a.m.                           

Breakfast Symposium

Non-CME Activity Hosted by Takeda Oncology

Introducing the First and Only Novel Targeted Therapy Approved for mCRC, Regardless of Mutation Status, in More Than a Decade

Farshid Dayyani, MD PhD

7 a.m.                 

Breakfast & View Exhibits

7:55 a.m.                           

Welcome & Announcements

Alan Saven, MD

Malignant Hematology

Moderator: Alan Saven, MD

8 a.m.                 

Myeloproliferative Neoplasms: 2024 Update

Brandi Reeves, MD

8:30 a.m.                           

Smoldering Multiple Myeloma

Morie Gertz, MD, MACP

9 a.m.                 

Management of MDS/AML in the Geriatric Patient

Courtney DiNardo, MD

9:30 a.m.                           

Panel Discussion/Q&A

10 a.m.               

Break & View Exhibits

10:30 a.m.         

Detangling New Approaches to Hairy Cell Leukemia – A Comb or a Brush?

David Hermel, MD

11 a.m.               

Advances in Frontline Treatment of FLT3-mutated AML

Nicholas Short, MD

11:30 a.m.         

BTK Refractory CLL

Susan O’Brien, MD

Noon                   

Panel Discussion/Q&A

12:30 p.m.         

Lunch

12:30 p.m.         

Lunch Symposium

Non-CME Activity Hosted by Pfizer

A Treatment Option for Patients with Relapsed or Refractory Multiple Myeloma

William Bensinger, MD

12:30 p.m.         

Lunch Symposium

Non-CME Activity Hosted by GSK

A New treatment Option for Patients with Primary Advanced or Recurrent dMMR/MSI-H Endometrial Cancer

Ivor Benjamin, MD

Malignant Hematology – Non-Hodgkin Lymphomas

Moderator: Marin Xavier, MD

1:30 p.m.                           

Frontline Treatment of DLBCL

Loretta Nastoupil, MD

2 p.m.                 

Updates in the Treatment of Relapsed DLBCL

Charalambos Andreadis, MD

2:30 p.m.                           

Management of Indolent NHL

Elizabeth Brem, MD

3 p.m.                 

Panel Discussion/Q&A

3:30 p.m.                           

Break & View Exhibits

Concurrent Breakout Sessions: Clinical Cases

4 p.m.                 

Breakout #1: Interesting Cases in Thrombosis

Stephan Moll, MD

Breakout #2: Interesting Cases in Platelet Disorders

Ted Warkentin, MD

Breakout #3: Interesting Cases in Bleeding

Alice Ma, MD

Breakout #4: Interesting Cases in Plasma Cell Dyscrasias

Morie Gertz, MD

5 p.m.                 

Adjourn

5:30 p.m.                

Dinner Symposium

Non-CME Activity Hosted by AstraZeneca

TRUQAP + fulvestrant: A Novel 2L Treatment Option for HR+/HER2- aBC or mBC With PIK3CA/AKT1/PTEN Alterations

Linnea Chap, MD

View Invitation (PDF, 1.4 MB)

5:30 p.m.

Dinner Symposium

Non-CME Symposium Hosted by Blueprint Medicines

The FIRST and ONLY Therapy Approved for Adults With Indolent Systemic Mastocytosis (ISM)

James McCloskey, MD

View Invitation (PDF, 580 KB)

6:45 a.m.                           

Breakfast Symposium

Non-CME Activity Hosted by Seagen

Adcetris+AVD: The First Regimen in 30 Years to Improve Overall Survival vs ABVD Alone

Elizabeth Brem, MD

7 a.m.                 

Breakfast & View Exhibits

7:50 a.m.                           

Welcome & Announcements

Mohammed Jaloudi, MD

Breast Cancer, Neuro-Oncology and Melanoma

Moderator: Mohammed Jaloudi, MD

8 a.m.                 

Breast Cancer in Pregnancy

Farah Nasraty, MD

8:30 a.m.                           

Anthracyclines in Early Breast Cancer – Do They Still Have a Role?

Virginia Borges, MD

9 a.m.                 

CDK4/6 Inhibitor Therapy in Early-stage HR+/HER2- Breast Cancer

Sarah Sammons, MD

9:30 a.m.                           

Panel Discussion/Q&A

10 a.m.               

Break & View Exhibits

10:30 a.m.         

Neuro-Oncology: 2024 Update

Tresa McGranahan, MD, PhD

11 a.m.               

Combination Immunotherapy in Melanoma

Justin Moyers, MD

11:30 a.m.         

Sequencing Therapies in Metastatic Urothelial Carcinoma

Petros Grivas, MD, PhD

Noon                   

Panel Discussion/Q&A

12:30 p.m.         

Lunch

12:30 p.m.         

Lunch Symposium

Non-CME Activity Hosted by Exelixis

A Combination Treatment for Patients with Advanced Renal Cell Carcinoma

Sandy Liu, MD

12:30 p.m.         

Lunch Symposium

Non-CME Activity Hosted by Pfizer

Clinical Case Reviews: Treatment of a Broad Range of Patients With HR+/HER2- Metastatic Breast Cancer

Anne O’Dea, MD

View Invitation (PDF, 220 KB)

GI and GYN Cancers

Moderator: Wesleigh Edwards, MD, PhD

1:30 p.m.                           

Artificial Intelligence in Oncology

Jacob Shreve, MD

2 p.m.                 

Integrating Immunotherapy into the Treatment of Cervical and Endometrial Cancers

Alexi Wright, MD

2:30 p.m.                           

New Approaches to Recurrent or Metastatic Ovarian Cancer

Oliver Dorigo, MD, PhD

3 p.m.                 

Panel Discussion/Q&A

3:30 p.m.                           

Break & View Exhibits

3:45 p.m.                           

Using ctDNA to Drive Decision Making in Adjuvant Chemotherapy of Colon Cancer

Stacey Cohen, MD

4:15 p.m.                           

Targeted Therapy Approaches for Upper GI Cancer

Matt Strickland, MD

4:45 p.m.                           

Perioperative Therapy of Resectable Non-small Cell Lung Cancer

Karen Reckamp, MD

5:15 p.m.                           

Panel Discussion/Q&A

5:45 p.m.                           

Final Adjournment

Please note: All times are listed in Pacific Time (PT). Topics, times and speakers are subject to change.